Discontinued — last reported Q3 '25
Xylem Share Buybacks increased by 56200.0% to $563.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4230.8%, from $13.00M to $563.00M. Over 4 years (FY 2021 to FY 2025), Share Buybacks shows a downward trend with a -31.5% CAGR.
High repurchases often signal management's confidence in the company's valuation or a strategy to improve earnings per share.
The cash outflow associated with the company buying back its own shares from the open market. This is a primary method f...
Common among mature, cash-generative companies; peers in the healthcare sector often balance this with R&D investment.
share_repurchases| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.00M | $0.00 | $0.00 | $51.00M | $1.00M | $0.00 | $0.00 | $8.00M | $1.00M | $1.00M | $15.00M | $15.00M | $3.00M | $1.00M | $1.00M | $13.00M | $0.00 | $1.00M | $1.00M | $563.00M |
| QoQ Change | — | -100.0% | — | — | -98.0% | -100.0% | — | — | -87.5% | +0.0% | >999% | +0.0% | -80.0% | -66.7% | +0.0% | >999% | -100.0% | — | +0.0% | >999% |
| YoY Change | — | — | — | — | +0.0% | — | — | -84.3% | +0.0% | — | — | +87.5% | +200.0% | +0.0% | -93.3% | -13.3% | -100.0% | +0.0% | +0.0% | >999% |